Please login to the form below
11
Revenue 2017AstraZeneca
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of AstraZeneca's 2013 sales performance.
AstraZeneca and Daiichi Sankyo share positive results from phase 3 lung cancer study
AstraZeneca (AZ) and Daiichi Sankyo have announced positive results from a late-stage study of their investigational TROP2-targeting antibody drug conjugate, datopotamab deruxtecan, in certain lung cancer patients.
AstraZeneca’s phase 3 liver cancer study shows continued survival benefit
AstraZeneca (AZ) has shared updated results from a late-stage study of its Imfinzi (durvalumab) plus Imjudo (tremelimumab) treatment plan in certain patients with hepatocellular carcinoma (HCC), the most common type
Driving conscious inclusion within organisations
Rebekah Martin is SVP of Reward, Inclusion &Talent Acquisition at AstraZeneca.
Using knowledge graphs to discover powerful new insights
cases. These ranged from drug discovery management to AstraZeneca’s application of the technology with chemical reactions, to predict new reactions and molecular synthesis – with the potential to possibly circumvent or ... Beyond AstraZeneca’s
VMLY&R Health appoints Natxo Diaz as global head of health craft
He has worked across a diverse range of therapeutic areas for clients including GSK, Pfizer, Novartis, Johnson &Johsnon, AstraZeneca, Gilead, Roche, Merck, Boehringer Ingelheim, Eli Lilly, Novo Nordisk, Takeda and Biogen.
[ Previous 5 results ] 6 7 8 9 10 11 12 13 14 15 [ Next 5 results ]
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Subscribe to our email news alerts
- AstraZeneca and Daiichi Sankyo share positive results from phase 3 breast cancer study
- ICR and Merck renew strategic alliance for development of new cancer drugs
- DeepMind’s AI tool classifies effects of mutations in genetic diseases
- CDC awards over $23m to Johns Hopkins Center for Health Security project
- Looking to start activity on a currently unpromoted pharmaceutical brand?
- Considering a portfolio review?
No results were found
PMHub
Four Health
Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
